Reverse quantum state engineering using electronic feedback loops

We propose an all-electronic technique to manipulate and control interacting quantum systems by unitary single-jump feedback conditioned on the outcome of a capacitively coupled electrometer and in particular a single-electron transistor. We provide a general scheme to stabilize pure states in the quantum system and employ an effective Hamiltonian method for the quantum master equation to elaborate on the nature of stabilizable states and the conditions under which state purification can be achieved. The state engineering within the quantum feedback scheme is shown to be linked with the solution of an inverse eigenvalue problem. Two applications of the feedback scheme are presented in detail: (i) stabilization of delocalized pure states in a single charge qubit and (ii) entanglement stabilization in two coupled charge qubits. In the latter example we demonstrate the stabilization of a maximally entangled Bell state for certain detector positions and local feedback operations.Comment: 23 pages, 6 figures, to be published by New Journal of Physics (2013

Novel mutations support a role for Profilin 1 in the pathogenesis of ALS

AbstractMutations in the gene encoding profilin 1 (PFN1) have recently been shown to cause amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disorder. We sequenced the PFN1 gene in a cohort of ALS patients (n = 485) and detected 2 novel variants (A20T and Q139L), as well as 4 cases with the previously identified E117G rare variant (∼ 1.2%). A case-control meta-analysis of all published E117G ALS+/− frontotemporal dementia cases including those identified in this report was significant p = 0.001, odds ratio = 3.26 (95% confidence interval, 1.6–6.7), demonstrating this variant to be a susceptibility allele. Postmortem tissue from available patients displayed classic TAR DNA-binding protein 43 pathology. In both transient transfections and in fibroblasts from a patient with the A20T change, we showed that this novel PFN1 mutation causes protein aggregation and the formation of insoluble high molecular weight species which is a hallmark of ALS pathology. Our findings show that PFN1 is a rare cause of ALS and adds further weight to the underlying genetic heterogeneity of this disease

A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype

We report on a family with occipital horn syndrome (OHS) diagnosed in the proband's late fifties. A novel ATP7A pathogenic variant (c.4222A > T, p.(Lys1408*)), representing the first nonsense variant and the second late truncation causing OHS rather than classic Menkes disease, was found to segregate in the family. The predicted maintenance of transmembrane domains is consistent with a residual protein activity, which may explain the mild clinical presentation

Quantum Feedback Control: How to use Verification Theorems and Viscosity Solutions to Find Optimal Protocols

While feedback control has many applications in quantum systems, finding optimal control protocols for this task is generally challenging. So-called "verification theorems" and "viscosity solutions" provide two useful tools for this purpose: together they give a simple method to check whether any given protocol is optimal, and provide a numerical method for finding optimal protocols. While treatments of verification theorems usually use sophisticated mathematical language, this is not necessary. In this article we give a simple introduction to feedback control in quantum systems, and then describe verification theorems and viscosity solutions in simple language. We also illustrate their use with a concrete example of current interest.Comment: 12 pages, revtex

FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis

Mutations in the SOD1 and TARDBP genes have been commonly identified in Amyotrophic Lateral Sclerosis (ALS). Recently, mutations in the Fused in sarcoma gene (FUS) were identified in familial (FALS) ALS cases and sporadic (SALS) patients. Similarly to TDP-43 (coded by TARDBP gene), FUS is an RNA binding protein. Using the zebrafish (Danio rerio), we examined the consequences of expressing human wild-type (WT) FUS and three ALS–related mutations, as well as their interactions with TARDBP and SOD1. Knockdown of zebrafish Fus yielded a motor phenotype that could be rescued upon co-expression of wild-type human FUS. In contrast, the two most frequent ALS–related FUS mutations, R521H and R521C, unlike S57Δ, failed to rescue the knockdown phenotype, indicating loss of function. The R521H mutation caused a toxic gain of function when expressed alone, similar to the phenotype observed upon knockdown of zebrafish Fus. This phenotype was not aggravated by co-expression of both mutant human TARDBP (G348C) and FUS (R521H) or by knockdown of both zebrafish Tardbp and Fus, consistent with a common pathogenic mechanism. We also observed that WT FUS rescued the Tardbp knockdown phenotype, but not vice versa, suggesting that TARDBP acts upstream of FUS in this pathway. In addition we observed that WT SOD1 failed to rescue the phenotype observed upon overexpression of mutant TARDBP or FUS or upon knockdown of Tardbp or Fus; similarly, WT TARDBP or FUS also failed to rescue the phenotype induced by mutant SOD1 (G93A). Finally, overexpression of mutant SOD1 exacerbated the motor phenotype caused by overexpression of mutant FUS. Together our results indicate that TARDBP and FUS act in a pathogenic pathway that is independent of SOD1

Daf-2 Signaling Modifies Mutant SOD1 Toxicity in C. elegans

The DAF-2 Insulin/IGF-1 signaling (IIS) pathway is a strong modifier of Caenorhabditis elegans longevity and healthspan. As aging is the greatest risk factor for developing neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), we were interested in determining if DAF-2 signaling modifies disease pathology in mutant superoxide dismutase 1 (SOD1) expressing C. elegans. Worms with pan-neuronal G85R SOD1 expression demonstrate significantly impaired locomotion as compared to WT SOD1 expressing controls and they develop insoluble SOD1 aggregates. Reductions in DAF-2 signaling, either through a hypomorphic allele or neuronally targeted RNAi, decreases the abundance of aggregated SOD1 and results in improved locomotion in a DAF-16 dependant manner. These results suggest that manipulation of the DAF-2 Insulin/IGF-1 signaling pathway may have therapeutic potential for the treatment of ALS

Identification of new HSPB8 variants linked to familial Amiotrophic Lateral Sclerosis

The Heat Shock Protein B8 (HSPB8) is a small heat shock protein involved in the proteostasis network. HSPB8, with its obligatory partner BAG3, promotes the removal of misfolded proteins and protein aggregates, via autophagy. We have demonstrated that the overexpression of HSPB8 enhances the clearance of soluble and insoluble form of mutated SOD1, the C-terminal TDP-43 fragments and RAN translated dipeptide of the C9ORF72 repeats, causative of Amyotrophic Lateral Sclerosis (ALS). Interestingly, mutations in HSPB8 (K141E/N/T) are found in diseases that affect neurons and muscle cells, like distal hereditary motor neuropathy type II and Charcot Marie Tooth (CMT) disease type2L. Using exome sequencing (NGS) on a large cohort of fALS patients, available at the Istituto Auxologico Italiano, novel HSPB8 gene variants predicted to be pathogenic in fALS have been identified. We performed preliminary studies aimed to characterize the behaviour of these new variants compared to the wild type form. We found that one of the ALS-associated HSPB8 variants: i) affects the capability of endogenous HSPB8 to bind to its partner BAG3 (required for HSPB8 stabilization and functions); ii) correlates with a reduced stability, although no changes of HSPB8 solubility was found; ii) presents an altered mobility in native Gel Electrophoresis, iv) reduces the pro-degradative power of HSPB8 on TDP-43 and mutant SOD1. These data strongly indicate that the novel HSPB8 variant may be involved in fALS pathogenesis

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

We have previously shown higher-than-expected rates of schizophrenia in relatives of patients with amyotrophic lateral sclerosis (ALS), suggesting an aetiological relationship between the diseases. Here, we investigate the genetic relationship between ALS and schizophrenia using genome-wide association study data from over 100,000 unique individuals. Using linkage disequilibrium score regression, we estimate the genetic correlation between ALS and schizophrenia to be 14.3% (7.05-21.6; P=1 × 10-4) with schizophrenia polygenic risk scores explaining up to 0.12% of the variance in ALS (P=8.4 × 10-7). A modest increase in comorbidity of ALS and schizophrenia is expected given these findings (odds ratio 1.08-1.26) but this would require very large studies to observe epidemiologically. We identify five potential novel ALS-associated loci using conditional false discovery rate analysis. It is likely that shared neurobiological mechanisms between these two disorders will engender novel hypotheses in future preclinical and clinical studies